Brief: Aptevo Therapeutics Files Provisional Patent For Fifth Bispecific Antibody Apvo711, Intended For Treatment Of Solid Tumors
09/01/2023 13:56
Jan 9 (Reuters) - Aptevo Therapeutics Inc APVO.O :
* APTEVO THERAPEUTICS FILES PROVISIONAL PATENT FOR FIFTH
BISPECIFIC ANTIBODY APVO711, INTENDED FOR TREATMENT OF SOLID
TUMORS
Source text for Eikon: ID:
Further company coverage: APVO.O
((reuters.briefs@thomsonreuters.com;))
Recent news on Aptevo Therapeutics
See all newsBrief: Aptevo Therapeutics - Enters Amendment No. 6 To Rights Agreement On October 23, 2026 - SEC Filing
U.S. STOCKS ON THE MOVE-Principal Financial Group, NetApp
U.S. STOCKS ON THE MOVE-Genesco, Fervo Energy, Tyson Foods
Aptevo Therapeutics reports early data for blood cancer therapy; shares fall
Aptevo Therapeutics Inc reports results for the quarter ended June 30 - Earnings Summary